IHC - B-Cell Leukemia/Lymphoma 2 (BCL2) Test Cost & Procedure

Lymphoma is currently the most prevalent type of blood cancer. Essentially, lymphomas are immunologic neoplasms that are biologically complex.

It has been discovered that malignant lymphocytes can quickly spread to the lymph nodes, spleen, bone marrow, blood, or other body organs. Tumors can also develop as they build up. The IHC-B-Cell-Leukemia-Lymphoma-2 test gives the clinician a comprehensive understanding of the state of the body's white blood cells at the time of the test. Consequently, the doctor can comprehend the problem more thoroughly. In turn, this benefits them.

Preparation for IHC

Since the test comprises the collection of fresh bone marrow, new or unfixed tissue, and a sample of peripheral blood, no special preparations are necessary. The patients can easily stick to their routine diet plan. However, patients are required to adhere to all of the doctor's fundamental instructions. Additionally, they must do well in updating the doctors on their medical background. Further, if they are allergic to any drugs or a particular class of medication, they must tell the doctors. The doctor selects how the test will be done and where the sample will come from based on all the information the patient has provided.

IHC - B-Cell Leukemia/Lymphoma 2 Test Applications

The IHC-B-Cell-Leukemia-Lymphoma-2 test effectively identifies malignant cells that develop from aberrant white blood cell proliferation. They help to describe the following things: Chronic lymphocytic leukemia-specific lymphocytosis. Mantle cell lymphoma and CLL. Extensive granular lymphocyte proliferations and promyelocytic leukemia against lymphoblastic leukemia. Indy in the depth of the Sézary syndrome. Adult T-cell leukemia or lymphoma and Non-Hodgkin lymphoma.

IHC - B-Cell Leukemia/Lymphoma procedure Test

When doing the IHC-B-Cell-Leukemia-Lymphoma-2 test, the immunophenotyping by flow cytometry procedure is rigorously adhered to. The first step is to inject a needle through the arm veins to collect 1 ml of peripheral blood. The patient's name is then carefully inscribed on the label of a glass container that contains fresh bone marrow for core biopsy. Lastly, RPMI is used to acquire new or unfixed tissue. The laboratory receives all of the samples for further analysis.